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Introduction Investigation of neuroanatomical correlates of cognition in Parkinson's 
disease (PD) has been confined to patients with earlier diagnosis. This study examined 
the relationship between brain structure and neuropsychological performance in multiple 
cognitive domains in a non-demented sample characterized by longstanding disease 
duration and severe motor symptoms.  
 
Methods Volumetric T1-weighted magnetic resonance imaging (MRI) and 
neuropsychological pre-surgical data were collected on a consecutive sample of 41 
patients being considered for deep brain stimulation (DBS). Voxel-based morphometry 
(VBM) was utilized to examine the relationship between grey matter (GM) density and 
executive functioning, processing speed, verbal fluency, and memory. 
 
Results Reduced GM density across multiple brain regions was associated with poorer 
executive functioning performance. This diffuse pattern encompassed Heschl’s gyrus and 
the parahippocampal gyrus of the temporal lobe, olfactory bulb and rolandic operculum 
of the frontal lobe, calcarine fissure and lingual gyrus of the occipital lobe, and the 
thalamus. No significant associations were found between GM density and performance 
on measures of processing speed, fluency, or memory. 
 
Conclusion The association of such a broad anatomical network with executive 
functioning may explain patterns of executive dysfunction demonstrated in PD. Given the 
extent of brain regions associated with executive function, we hypothesize that this aspect 
of cognition may be uniquely vulnerable to diffuse pathology. Thus, this may lend 
understanding as to why executive dysfunction is a predominant impairment in PD, even 
in individuals without dementia. 
 
 
Key Words: Parkinson’s disease, neuroanatomical correlates, cognition, executive 
functioning, neuropsychology, voxel-based morphometry (VBM) 
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Introduction 
Cognitive dysfunction in Parkinson’s disease (PD) is a primary predictor of poor 
prognosis.(1) Beyond the impact of motor impairment on disability, cognitive deficits are 
significantly associated with functional decline(2) and reduced quality of life.(3) It is 
estimated that 24-31% of PD patients have dementia.(4) Even for those who do not meet 
criteria for a dementia diagnosis, cognitive deficits have been demonstrated across a 
range of cognitive domains. Prevalence of cognitive deficits has been shown to increase 
with disease duration and severity.(5) 
 One possible mechanism for cognitive deficits evidenced in PD is cerebral 
atrophy. Studies have consistently demonstrated widespread cortical atrophy for PD 
patients with dementia(6-12) in addition to atrophy of subcortical areas including the 
hippocampus,(7, 11-13) limbic structures,(7, 10, 12) and caudate.(11, 12) Even more 
notable are studies that have demonstrated atrophy in the brains of individuals with PD 
compared to healthy controls. Significant reductions in grey matter volume have been 
shown in the frontal and temporal lobes,(6, 8, 14) parietal and occipital lobes,(8) 
hippocampus and anterior cingulate.(13) Such neuroanatomical differences have been 
evidenced even in early, untreated PD populations.(6, 8, 14) These findings can 
contribute to current understandings of the cognitive pathophysiology of PD. 
 While loss of dopaminergic neurons in the basal ganglia is the accepted 
pathophysiological mechanism for motor dysfunction in PD, there is a lack of 
consistency in relating differential patterns of brain structure to PD nonmotor 
symptoms.(15) It has been proposed that differences in structural brain volume may 
represent the biological substrates for nonmotor symptoms in PD, particularly cognitive 
deficits. 
   While previous research has examined this question in the context of categorical 
disease conditions (e.g., dementia vs. mild cognitive impairment vs. no dementia), few 
studies have assessed neuroanatomical correlates of performance in specific cognitive 
domains within the spectrum of normal cognitive functioning that exists in the PD 
population.(12, 16, 17, 18) Furthermore, these investigations have focused exclusively on 
patients with early-stage disease. To our knowledge, we are the first group to examine the 
relationship between brain structure and specific cognitive domains in a non-demented 
PD population characterized by longstanding disease duration and severe motor 





 Archival pre-surgical data from a consecutive sample of 56 individuals with PD 
who underwent DBS between 2009 and 2012 were used for this study. Preoperative 
assessment included neurological examination, neuropsychological evaluation, and 
neuroimaging. Fifteen subjects were excluded from analyses due to poor magnetic 
resonance imaging (MRI) scan quality. Analyses were conducted on the remaining 41 
subjects. Patient data were obtained from the Center for Neuromodulation at the Ohio 
State University (OSU) Wexner Medical Center. This study was approved by the 
university’s Institutional Review Board. 
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Assessments 
 Subjects with idiopathic PD with a history of problematic motor fluctuations, 
medication refractory tremor, or medication intolerance as determined by evaluation by a 
Movement Disorder Neurologist were referred for DBS consideration. PD diagnosis was 
confirmed by a Neurological Specialist with Movement Disorder training using the UK 
Brain Bank criteria for Parkinson’s Disease.(19) Motor symptom severity was assessed 
using the Unified Parkinson’s Disease Rating Scale (UPDRS-III) off levodopa 
medication. Total medication dose for PD was calculated in levodopa equivalents using 
previously published methods.(20) 
The neuropsychological battery was a comprehensive evaluation across several 
cognitive domains. Composite scores were created for analyses, as follows: Executive 
Functioning – Trails B and Stroop Color Word; Processing Speed – Trails A, Stroop 
Word, and Stroop Color; Fluency – Animal Naming and Controlled Oral Word 
Association Test (FAS); and Memory - California Verbal Learning Test-Long Delay Free 
Recall (CVLT-II). Raw scores on these measures were converted to demographically 
corrected T-scores; composite scores were calculated by averaging T-scores of the 
measures within each domain. A notable strength of the composite scores is that the 
executive functioning composite reflects a purer metric of cognitive flexibility, as the 
processing speed composite accounts for the more rudimentary attentional and speeded 
components of these tasks. Clinical interview and neuropsychological evaluation 
confirmed the absence of dementia, according to the fourth edition of the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV-TR).(21) Depression was assessed with 
the Beck Depression Inventory (BDI-II) or the Geriatric Depression Scale (GDS), as 
clinically indicated.  
 
Neuroimaging and Data Analysis 
MRI Acquisition 
 Volumetric contrast T1-weighted MRIs were acquired from scanners at the OSU 
Martha Morehouse Plaza and Wexner Medical Center. Of the 41 patients, 16 were 
imaged on 1.5-Tesla machines: a 1.5-T GE Medical Systems Signa HDxt (n = 8) and a 
1.5-T Siemens Espree (n = 8), whereas 25 patients were imaged on 3.0-Tesla scanners: a 
3-T Siemens Verio (n = 17) and 3-T Philips Medical Systems Achieva (n = 8). MRI 
scanner parameters for both 1.5-Tesla scanners were as follows: TR (repetition time) = 
12.0 ms; TE (echo time) = 4.2 ms; TI (inversion time) = 600 ms; acquisition matrix 512 × 
512; ST (slice thickness) = 1.2 mm; and flip angle = 15˚. The 3-T Siemens Verio 
parameters were: TR = 6.5; TE = 2.5; acquisition matrix 320 × 320; ST = 0.9; and flip 
angle = 10.5˚. The 3-T Philips Medical Systems Achieva parameters were: TR = 7.5; TE 
= 3.7; acquisition matrix 240 × 240; ST = 2.0; and flip angle = 8˚. All images were 
obtained axially in uncompressed Digital Imaging and Communications in Medicine 
format and converted into Nifti format for processing and analysis. 
 
MRI Data Preprocessing 
MRIs were visually rated to ensure scan quality. Of the original 56, 15 scans were 
omitted due to excessive noise and movement. Thus, analyses were conducted on the 
remaining 41 subjects. Scans were corrected for radiofrequency inhomogeneity using the 
Statistical Parametric Mapping toolbox (SPM8, Wellcome Department of Cognitive 
Ryan Joseph Tran  Undergraduate Research Thesis 
 
6  March, 2016 
 
Neurology, http://www.fil.ion.ucl.ac.uk/spm). Skull-stripping was performed using an in-
house Matlab 8.2 (MathWorks) script to prevent extrabrain voxels from being classified 
as grey matter. 
 
Voxel-Based Morphometry 
Voxel-based morphometry (VBM) refers to the voxel-wise comparisons of 
regional grey matter volume and density.(22) In particular, unmodulated VBM (without 
brain region scaling) was performed, representing differences in GM concentration or 
“relative density” rather than volumetric differences. Each patient's preoperative brain 
scan underwent a procedure of segmentation (into grey matter, white matter, and 
cerebrospinal fluid) and joint normalization (to standard space) using the SPM8 Matlab 
software suite. Brains were normalized to custom older adult templates(23) in MNI space 
to equate for differences in overall head size between subjects. Images were then 
smoothed using a 10mm Gaussian kernel to suppress noise and effects due to residual 
differences in gyral anatomy. The VBM processing steps are depicted in Figure 1. 
 
Statistical Analysis 
To determine whether a patient’s baseline cognition relates to extent of grey 
matter atrophy, individual voxel-wise multiple regressions were performed correlating 
grey matter density to each of the four cognitive domain scores. Confounding factors 
with a potential to influence grey matter density (age and disease duration) were included 
as covariates in the model. Determination as to which of four hospital scanners was used 
for preoperative imaging was primarily random (based on scanner availability), except 
for a few participants being excluded from scanning on the 3.0-T Philips magnet due to 
requiring anesthesia for severe movements. Orthogonal contrast coding was utilized to 
assess the effect of different field strengths (1.5-T vs. 3.0-T) and scanner types (1.5-T GE 
vs. 1.5-T Siemens; 3.0-T Philips vs. 3.0-T Siemens) to determine whether inter- and 
intra-scanner groups differentially affected GM classification. Systematic differences in 
grey matter classification were observed between the two field strengths and within the 
two 3.0-T scanner types, but not within the two 1.5-T scanner types. Thus, two dummy 
coded dichotomous nuisance covariates were included in the final model to account for 
the effect of scanner type on GM classification. 
Focal changes in grey matter were identified using paired t tests at individual 2-
mm isometric voxels (i.e., voxel-wise statistics). Voxel-wise beta coefficient t statistics 
for each domain of cognitive performance were thresholded at α uncorrected = 0.05 (t = 
±2.0211). More spatially diffuse changes in grey matter were quantified by testing for 
increases over a significant number of adjacent voxels (i.e., cluster-wise statistics). 
Correction for family-wise error by use of nonparametric permutation procedures(24) (n 




The sample consisted of 41 participants, all of whom were Caucasian and 
predominantly male. Demographic and clinical characteristics of the sample are 
presented in Table 1. 
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Cluster-wise analysis revealed that GM density was inversely associated with age 
(cluster size = 379,353 voxels, p=.01) and positively associated with the composite 
executive function measure (cluster size = 217,375 voxels, p<.05) (Figure 2). The 
significant cluster for executive function represents a diffuse pattern of cerebral atrophy 
that includes areas within frontal, parietal, occipital, and temporal cortices; insular and 
cingulate cortices; subcortical areas including the amygdala, hippocampus, basal ganglia, 
and thalamus; and cerebellum. Specifically, the most salient regions included Heschl’s 
gyrus (mean β= .0029), thalamus (mean β= .0027), olfactory bulb (mean β= .0022), 
calcarine fissure (mean β= .0021), rolandic operculum (mean β= .0017), lingual gyrus 
(mean β= .0017) and parahippocampal gyrus (mean β= .0016). Locations of greatest 
salience are presented in Table 2. No significant associations or trends were observed 
between GM density and the composite scores for processing speed, fluency, or memory 
(p>.34). Disease duration was also not predictive of GM density (p=.59).  
 
Discussion 
Poorer executive function was associated with diminished grey matter density 
across diffuse brain regions encompassing areas within all four lobes; insular and 
cingulate cortices; subcortical areas including striatum, limbic structures, and thalamus; 
and cerebellum. No significant associations were demonstrated between GM density and 
processing speed, fluency, or memory.  
 Previous studies that have examined the neuroanatomical correlates of executive 
function in individuals with Parkinson’s disease without dementia have yielded varied 
and inconsistent results. Camicioli et al.(16) found an association between a composite 
index of executive function (similarly comprised of Stroop, Trails, and digit ordering) 
and grey matter atrophy in the caudate, middle temporal gyri, precuneus, and cerebellum. 
Mak et al.(17) demonstrated significant correlations between insular and middle temporal 
atrophy and executive dysfunction as measured by the Frontal Assessment Battery and 
clock drawing test. Performance on other less conventional measures thought to reflect 
executive function, such as Raven Colored Progressive Matrices, has been associated 
with grey matter density in the dorsolateral prefrontal cortex and the parahippocampal 
gyrus.(12) Inconsistencies in these studies are likely attributable to differences in sample 
characteristics and cognitive measures.  
 Furthermore, previous research that has investigated grey matter integrity and 
performance on specific domains of cognition in individuals with PD without dementia 
has exclusively focused on patients with early-stage disease. To our knowledge, this is 
the first study investigating the neuroanatomical correlates of cognitive functioning in 
individuals with longstanding Parkinson’s disease and severe motor impairment in 
absence of dementia. Our patient sample of DBS qualifiers provided a unique cohort of 
PD patients in regard to their motor and cognitive symptom presentation and the 
medically refractory nature of their disease process. It is conceivable that this patient 
sample may be unique in regard to cognitive resiliency and/or neuropathology.  
 The diffuse anatomical associations with executive dysfunction demonstrated in 
this study are consistent with patterns found not only in PD populations, but also in other 
neurological disorders, including corticobasal syndrome,(25) Alzheimer’s disease, and 
Mild Cognitive Impairment.(26) Other researchers have hypothesized that the diffuse 
anatomical associations with executive function reflect other components (e.g., motor, 
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visual) inherent in neuropsychological measures. However, our study accounted for this 
by covarying out processing speed (composite of Trails A, Stroop Color, and Stroop 
Word) in our regression model to achieve a “purer” metric of the mental flexibility 
component of executive functioning. That the anatomical correlates with executive 
function in this study remained diffuse provides evidence that a large cortico-striatal-
thalamic-cerebellar network is involved in executive function, and, more specifically, 
with mental flexibility. We hypothesize that, in the context of PD, the involvement of a 
broad anatomical network may explain why executive dysfunction is a predominant 
impairment in PD, even in those without dementia. Since executive functioning is 
associated with a vast number of brain regions, pathology in any of these areas could 
theoretically result in executive deficits. The association of such a large network with 
executive functioning may also explain why such deficits are often present even at early 
stages of PD and tend to worsen with disease progression.(27)  
As mentioned above, previous research on individuals with early-stage disease 
has revealed associations between executive functioning and frontal, temporal, caudate, 
and cerebellar regions. Our study examined a population with longer disease duration and 
demonstrated a broader pattern of neuroanatomical associations with executive function. 
Such findings are consistent with recent theories regarding disease progression and 
network decentralization. In a longitudinal study of brain network topology in PD using 
magnetoencephalography,(28) progressive decreases of local clustering in multiple 
frequency bands and progressively decentralized, less-integrated network configurations 
were demonstrated during both motor and cognitive tasks. Additionally, a recent fMRI 
study of altered resting state brain networks in PD, independent of cognitive variables, 
identified decreases in local and global functional connectivity as well as various 
compensatory increases in the sensorimotor module connectedness.(29) Since our 
modality for GM analysis of cognition demonstrates the diffuse clustering and 
decentralization in areas of decreased functional connectivity, our findings support the 
notion that as disease progresses, increased and seemingly more “random” network 
recruitment subserves specific compensatory cognitive functions (e.g., executive 
functioning).   
One limitation of this study is that these results were generated from a highly 
specific patient sample (PD patients being considered for DBS) and therefore are not 
generalizable to all non-demented individuals with PD, even those with severe motor 
impairment and long disease duration. The possibility of selection bias cannot be ruled 
out given that various psychosocial factors may influence referral for DBS and/or a 
person’s willingness to consider DBS. Furthermore, our sample was entirely Caucasian, 
limiting generalizability to other ethnic groups. Additionally, the cross-sectional nature of 
this study precludes causal inference that atrophy of the aforementioned brain regions 
yields declines in executive functioning. Longitudinal research is needed to further 
investigate the cognitive and neuropathological trajectories of individuals with 
Parkinson’s disease.  
 In summary, this study expanded upon previous research investigating the 
neuroanatomical correlates of cognitive functioning in PD by examining DBS candidates 
who are non-demented, but characterized by long disease duration and severe motor 
impairment. Correlating GM density with executive functioning revealed a diffuse, global 
pattern of neuroanatomical regions. We hypothesize that these findings, supporting a 
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large brain network for executive functioning may lend understanding to the 
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Figures 
Figure 1 VBM processing steps for one subject. 
 
(A) Original T1 contrast-weighted image (B) After skull-stripping and inhomogeneity 
correction (C) Segmented in native space (D) After joint segmentation and normalization 
to custom older adult templates (E) Smoothed with a 10mm Gaussian kernel to suppress 
noise and effects due to residual differences in gyral anatomy. 
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Figure 2 Cluster-wise analysis of GM density and executive functioning in patients with 
longstanding PD without dementia.  
Areas of higher beta value (red) represent a greater association. Images are oriented in 
axial view following neurological convention (i.e., right hemisphere of brain corresponds 
to right side of image).  
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Tables 
Table 1 Sample demographics and clinical characteristics (n=41). 
Table 1 Sample demographics and clinical characteristics (n=41) 
 Mean ± SD Range 
Age 60.6 ± 9.7 39 - 81 
Gender (M:F) 34:7  
Handedness (R:L) 34:7  
Education 14.4 ± 3.2   9 - 23 
PD Duration, years 14.1 ± 6.5   6 - 40 
Unified Parkinson’s Disease Rating Scale (UPDRS III) 44.2 ± 12.6 26 - 72 
Levodopa-equivalent dose, mg 825 ± 623 0 - 2500 
Executive Function   
   Trails B 35.1 ± 13.1   7 - 59 
   Stroop Color-Word 35.5 ± 11.2 19 - 66 
Processing Speed   
   Trails A 38.6 ± 12.0 12 - 60 
   Stroop Word 38.1 ± 10.6 19 - 61 
   Stroop Color 33.6 ± 10.8 19 - 63 
Fluency   
   Animal Naming 43.8 ± 11.7 19 - 69 
   Verbal Fluency (FAS) 41.9 ± 12.5 21 - 73 
Memory   
   California Verbal Learning Test Long-Delay Free         
Recall (CVLT-LDFR) 
43.3 ± 12.8 17 - 77 
Beck Depression Inventory-II (BDI-II) (n=30) 10.9 ± 6.9 0 - 32 
Geriatric Depression Scale (GDS) (n=8) 7.3 ± 4.8 1 - 14 
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Table 2 Location and MNI coordinates of most salient regions 
 
Table 2 Location and MNI coordinates of most salient regions 
Location Mean β  MNI Coordinates 
   x y z 
Heschl_R 0.00288836'  46' )24' 14'
Thalamus_R 0.002716485'  10' )26' 14'
Olfactory_R 0.00215577'  2' 22' )6'
Calcarine_L 0.002128369'  0' )66' 14'
Olfactory_L 0.002065491'  )2' 12' )14'
Thalamus_L 0.002012251'  )8' )28' 12'
Lingual_L 0.001728793'  )2' )66' 8'
Rolandic_Oper_R 0.001713462'  54' )20' 12'
Calcarine_R 0.001688665'  2' )66' 16'
Parietal_Inf_R 0.001632348'  44' )46' 54'
ParaHippocampal_R 0.001603022'  32' )16' )30'
Cuneus_R 0.001582233'  6' )74' 34'
Rectus_L 0.001446529'  0' 36' )16'
Temporal_Pole_Sup_R 0.001445966'  34' 20' )32'
Lingual_R 0.001373193'  22' )66' )10'
Insula_R 0.001327323'  44' 14' 0'
Occipital_Inf_R 0.001325408'  34' )88' )2'
Frontal_Inf_Oper_R 0.001208333'  44' 16' 2'
Hippocampus_R 0.001202587'  14' )32' 10'
Temporal_Mid_R 0.001193843'  46' )54' 14'
MNI – Montreal Neurological Institute 
 
 
